跳至主要内容
临床试验/ISRCTN19641893
ISRCTN19641893进行中(未招募)未知

Personalized nutrition for cancer patients in chemotherapy treatment according to erythrocyte membrane lipid profile.

AZTI0 个研究点目标入组 52 人开始时间: 2019年5月20日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients of any type of Cancer who initiate a chemotherapy treatment, and who understand their participation in the trial.
  • 2. Neoadjuvant, adjuvant and metastatic treatments will be considered.
  • 3. A life expectancy of at least 1 year.
  • 4. Age less than 70 years.
  • 5. A body mass index (BMI) less than 35.

排除标准

  • 1. Diabetic or with other risk factors related to lipid metabolism such as metabolic syndrome.
  • 2. Allergy to fish.
  • 3. Severe malnutrition, cachexia or anorexia.

研究者

发起方
AZTI

相似试验

Personalized nutrition for cancer patients in... | 临床试验